Novo Nordisk A/S

CPSE:NOVO B Stock Report

Market Cap: DKK 4.0t

Novo Nordisk Balance Sheet Health

Financial Health criteria checks 4/6

Novo Nordisk has a total shareholder equity of DKK112.5B and total debt of DKK57.1B, which brings its debt-to-equity ratio to 50.7%. Its total assets and total liabilities are DKK369.4B and DKK256.9B respectively. Novo Nordisk's EBIT is DKK118.6B making its interest coverage ratio -225. It has cash and short-term investments of DKK62.7B.

Key information

50.7%

Debt to equity ratio

DKK 57.06b

Debt

Interest coverage ratio-225x
CashDKK 62.65b
EquityDKK 112.52b
Total liabilitiesDKK 256.86b
Total assetsDKK 369.38b

Recent financial health updates

Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Jul 27
Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Apr 14
Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Dec 12
Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

Aug 02
These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

Recent updates

Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Jul 27
Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Should You Be Adding Novo Nordisk (CPH:NOVO B) To Your Watchlist Today?

Jul 05
Should You Be Adding Novo Nordisk (CPH:NOVO B) To Your Watchlist Today?

A Look At The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)

Jun 09
A Look At The Fair Value Of Novo Nordisk A/S (CPH:NOVO B)

Novo Nordisk's (CPH:NOVO B) Promising Earnings May Rest On Soft Foundations

May 09
Novo Nordisk's (CPH:NOVO B) Promising Earnings May Rest On Soft Foundations

Results: Novo Nordisk A/S Beat Earnings Expectations And Analysts Now Have New Forecasts

May 04
Results: Novo Nordisk A/S Beat Earnings Expectations And Analysts Now Have New Forecasts

The Price Is Right For Novo Nordisk A/S (CPH:NOVO B)

Apr 28
The Price Is Right For Novo Nordisk A/S (CPH:NOVO B)

Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Apr 14
Does Novo Nordisk (CPH:NOVO B) Have A Healthy Balance Sheet?

Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?

Mar 18
Do Novo Nordisk's (CPH:NOVO B) Earnings Warrant Your Attention?

Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings

Dec 30
Novo Nordisk A/S' (CPH:NOVO B) Price In Tune With Earnings

Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Dec 12
Novo Nordisk (CPH:NOVO B) Seems To Use Debt Rather Sparingly

Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Nov 24
Estimating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Calculating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

Aug 20
Calculating The Intrinsic Value Of Novo Nordisk A/S (CPH:NOVO B)

These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

Aug 02
These 4 Measures Indicate That Novo Nordisk (CPH:NOVO B) Is Using Debt Safely

Financial Position Analysis

Short Term Liabilities: NOVO B's short term assets (DKK177.5B) do not cover its short term liabilities (DKK187.9B).

Long Term Liabilities: NOVO B's short term assets (DKK177.5B) exceed its long term liabilities (DKK69.0B).

Debt to Equity History and Analysis

Debt Level: NOVO B has more cash than its total debt.

Reducing Debt: NOVO B's debt to equity ratio has increased from 8% to 50.7% over the past 5 years.

Debt Coverage: NOVO B's debt is well covered by operating cash flow (202.1%).

Interest Coverage: NOVO B earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y